Cited by 10Spectroscopy Techniques in Biomedical and Chemical ResearchOsteoarthritis Treatment and MechanismsOptical Coherence Tomography Applications

Raman spectroscopic probe provides optical biomarkers of cartilage composition predictive of tissue function

Open access
Kazemi, Masumeh, Yu, Chenhao, Mehrotra, Dev R., Ersland, Erik E., Zbyn, Stefan, Korna, Farida, Staffa, Steven J., Engiles, Julie B. +6 more·2025·Osteoarthritis and Cartilage

Abstract

Objective The diagnosis of early osteoarthritis when therapeutic interventions may be most effective at reversing cartilage degeneration presents a clinical challenge. We describe a Raman arthroscopic probe and spectral analysis that measures biomarkers reflective of the content of predominant cartilage extracellular matrix (ECM) constituents-glycosaminoglycans (GAG), collagen, water-essential to cartilage function. We compare the capability of Raman-probe-derived biomarkers to predict functional properties of cartilage to quantitative MRI and histopathology assessments. Design Osteochondral blocks were sectioned from 6 bovine femoral condyles with no macroscopic injury (n=62 blocks) and 6 condyles with a focal chondral lesion (n=32 blocks), but no macroscopic degeneration of surrounding cartilage (n=34 blocks). Blocks from 10 human knees were further analyzed (age 27-75; n=235 blocks). Using a custom arthroscopic Raman spectroscopy probe, spectra of chondral layers were measured and subjected to multivariate linear decomposition to extract ECM biomarker scores, reflecting the contribution of each ECM constituent to the spectra. Blocks were further analyzed for elastic modulus, T2/T2* MRI relaxation times, and OARSI scores. Results For bovine tissues, Raman biomarkers revealed depleted GAG and cartilage softening peripheral to the lesion despite no macroscopic degeneration. Raman biomarkers accounted for 78% of GAG content variation and 71% of modulus variation. For human tissues, Raman biomarkers accounted for 71% of modulus variation. Raman biomarkers accounted for a greater variation of modulus (71%-72%) than OARSI (12-54%), T2* (15%-27%), or T2 (25%-30%). Conclusions These data support the application of Raman-probe-derived biomarkers for molecular assessment of key ECM constituents that define cartilage properties in health and disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.joca.2024.12.008

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Optical imaging excels in preclinical models but faces clinical translation challenges due to limited tissue penetration.

    “while optical imaging excels in preclinical models but faces clinical translation challenges due to limited tissue penetration [167].”

    From Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease (2025) · cites this paper as [167]

    The Discussion (page unavailable) describes potential preclinical uses and acknowledges challenges in moving ex-vivo Raman measurements into surgical settings. The Methods report approximately 270 μm of tissue penetration, but the paper does not say that limited penetration causes clinical translation challenges for optical imaging generally, or that optical imaging excels in preclinical models. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • SPECT offers cost-effective bone turnover assessment.

    “SPECT offers cost-effective bone turnover assessment”

    From Biomarker-Guided Imaging and AI-Augmented Diagnosis of Degenerative Joint Disease (2025) · cites this paper as [167]

    The Introduction describes a need for a low-cost platform to assess cartilage composition, and the Methods discuss quantitative MRI; neither addresses SPECT. Searches for SPECT and bone turnover found no passage assessing SPECT’s cost or its use for bone turnover assessment. Page numbers were not available in our copy. (LLM, conf=0.77)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kazemi, M., Yu, C., Mehrotra, D. R., Ersland, E. E., Zbyn, S., Korna, F., Staffa, S. J., Engiles, J. B., Li, X., Schaer, T. P., Grinstaff, M. W., Bergholt, M. S., Snyder, B. D., & Albro, M. B.
Affiliations
  • Boston University (US)
  • Boston Children's Hospital (US)
  • University of Pennsylvania (US)
  • Cleveland Clinic (US)
  • King's College London (GB)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Albro, Michael B.
Venue
Osteoarthritis and Cartilage
Publisher
Elsevier BV
Published
2025-04
Volume
33
Issue
4
Pages
461-472
ISSN
1063-4584 (ISSN-L)
OpenAlex
W4406704875
Cited by
10
References
52
Citations by year
2026: 5 · 2025: 5
FWCI
3.77
Type
journal article
Language
en
Open access
Locations
  • Osteoarthritis and Cartilage (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR081393)
  • Arthritis Foundation
  • National Institutes of Health
  • Boston University
  • Missouri Broadcasters Association
  • Musculoskeletal Transplant Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Spectroscopy Techniques in Biomedical and Chemical Research
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Physical Sciences › Engineering › Biomedical Engineering › Optical Coherence Tomography Applications
Keywords
Raman spectroscopy, cartilage matrix, glycosaminoglycans, collagen, cartilage water content, early osteoarthritis, cartilage defects, OARSI score, cartilage degeneration, quantitative MRI, knee cartilage
MeSH terms
Adult, Aged, Animals, Arthroscopy, Cartilage, Articular, Cattle, Collagen, Extracellular Matrix, Female, Glycosaminoglycans, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Spectrum Analysis, Raman, Biomarkers, Osteoarthritis, Knee

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review